JAMA Network Home
Sign In
JAMA Insights

Psilocybin

JAMA 10.1001/jama.2026.11874

September 10, 2026 at 11:00 AM EDT

Read the full article

This JAMA Insights discusses the medical use of psilocybin, particularly for depression treatment, including emerging potential indications, safety, and future use.

Corresponding Author: Joshua D. Rosenblat, MD, MSc, University Health Network, 399 Bathurst St, Main Pavilion 7-424, Toronto, ON M5T 2S8, Canada (joshua.rosenblat@uhn.ca).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.11874?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091026

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks